Starpharma Holdings Limited (SPL)

 NULL
   
  • 52 Week High: NULL
  • 52 Week Low: $0.09
  • Currency: Australian Dollars
  • Shares Issued: 371.69m

SPL Overview

Starpharma Holdings Limited develops dendrimer nanotechnology products for pharmaceutical, life-science and other applications. Its lead product is VivaGel, a gel-based vaginal microbicide to protect women from the sexually transmitted infections, HIV and genital herpes.

3 Month Chart

3 Month Chart

1 Year Chart

1 Year Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0%
Div Cover n/a
Op Mrgn -503.0%
ROCE n/a
Latest F'cast
P/E n/a
PEG n/a
Pr/Revenue 29.1
Pr/Book 1.2
Latest F'cast
Revenue -30.5%
PBT n/a
EPS n/a
DPS n/a

SPL Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-06 0.57 (7.52) (6.00)¢ n/a n/a n/a n/a 0.0%
30-Jun-07 1.46 (7.97) (4.00)¢ n/a n/a n/a n/a 0.0%
30-Jun-08 1.41 (8.22) (4.00)¢ n/a n/a n/a n/a 0.0%
30-Jun-09 2.02 (4.33) (2.00)¢ n/a n/a n/a n/a 0.0%
30-Jun-10 1.40 (6.38) (3.00)¢ n/a n/a n/a n/a 0.0%

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are end of day values only.

Note 2: Forecast figures based on normalised accounts.

 

SPL Market Data

Currency Australian Dollars
% Change 0.00 %
52 Week High NULL
52 Week Low $0.09
Shares Issued 371.69m

Top of Page